What’s Going On With eFFECTOR Therapeutics Stock Today?
eFFECTOR Therapeutics Inc (NASDAQ: EFTR) is trading higher Monday after Cantor Fitzgerald initiated coverage on the stock.
Cantor Fitzgerald analyst Louise Chen initiated coverage on eFFECTOR Therapeutics with an Overweight rating and announced a price target of $50.